Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts

Abstract

Background:Lymphatic filariasis (LF) is endemic in 83 countries and territories, with more than a billion people at risk of infection. In view with the global elimination, mass drug administration (MDA) with single dose of diethylcarbamazine and albendazole tablets was carried out for the eligible population in Bagalkot and Gulbarga districts.Objective:Assess coverage of MDA against LF in Bagalkot and Gulbarga districts.Materials and Methods:In this cross-sectional coverage evaluation survey, one urban and three rural clusters were selected randomly in each district. The data were collected in a pretested performa, computed and analyzed using SPSS-10 to calculate frequencies and proportions.Results:A total of eight clusters in two districts resulted in a total study population of 1,228 individuals. The overall compliance rate in Bagalkot district was 78.6% and in Gulbarga district it was only 38.8%. The prime reason for noncompliance was fear of side effects and not received tablets.Conclusion:There is an urgent need for more effective drug delivery strategies to improve the compliance in both the districts.

Mass Drug Administration Coverage Evaluation Survey for Lymphatic Filariasis: An Experience from Paschim Bardhaman District, West Bengal

“…10 Compliance for both the drugs was found to be 84.6% in this study, the result being better than that observed by Patel et al in two districts of Karnataka in 2010. 1 In this study, 30.3% population swallowed drug in the presence of drug distributor (supervised coverage), which is lower as compared to study done by Ukarande et al where the same was 84.15%. 11 This difference might be due to different study settings.…”

“…1 In India, in 2017, indigenous cases of filariasis have been reported from about 256 districts in 21 states/ Union Territories, with about 600 million people at risk of infection. 2 The Government of India is signatory to the World Health Assembly Resolution in 1997 for Global Elimination of LF.…”

Mass Drug Administration Coverage Evaluation for Elimination of Lymphatic Filariasis in Nagpur District of Maharashtra

“…[18] Different studies gave different explanations for reason for non-compliance [9][10][11][12][13][14][15][16][17] In this study, only 6 persons (1.38%) had mild adverse reactions like nausea, vomiting, mild fever etc after consuming DEC. Consistent results were reported by Jothula KY etal, Prasad V G et al found 1.14%, 1.81% of adverse effects after consuming DEC. (12), (19) This study showed 86.67% households were aware regarding MDA activity from various sources like ASHA, anganwadi workers, health workers, mike announcement etc.…”

“…Several other studies across India revealed varied compliance of MDA ranging from 38.8% to 81.15%. [10][11][12][13][14][15] MDA should be implemented in more than 85% of the population in endemic areas and must be sustained for at least five years so that it will interrupt the transmission of filariasis. (3) However in this survey, the effective coverage rate was 77.78% which was lower than the standard target level.…”

Report on evaluation of mass drug administration campaign of 2014-15 against filariasis in Raichur, Karnataka, India

“…This is much lesser than the study done by Patel (78.6%) in the Bagalkot district (2010) and higher in the Gulbarga District (38.8%) in the year 2010. 6 On the other hand, the compliance was as high as 85.6% in an independent external evaluation of MDA in Udupi district. 8 Similar observations were made by Pradeep Kumar in Gujarat state and by Mahalakshmy T at Puducherry, where compliance was 89% and 88.7%, respectively.…”